Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Radiation Protection of Murine Intestine by WR-2721, 16, 16-Dimethyl Prostaglandin E2, and the Combination of Both Agents

Wayne R. Hanson
Radiation Research
Vol. 111, No. 2 (Aug., 1987), pp. 361-373
DOI: 10.2307/3576992
Stable URL: http://www.jstor.org/stable/3576992
Page Count: 13
  • Read Online (Free)
  • Download ($10.00)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Radiation Protection of Murine Intestine by WR-2721, 16, 16-Dimethyl Prostaglandin  E2, and the Combination of Both Agents
Preview not available

Abstract

The survival of murine intestinal clonogenic cells (ICC) and the survival of mice after whole-body exposure to 137 Cs irradiation were used to measure radiation protection by ethiophos (WR-2721), 16, 16-dimethyl prostaglandin E2, and the combination of the two. Doses from 2 to 12.5 mg/mouse of WR-2721 increased cell survival linearly from 3.2 ± 0.3 in controls given 15.0 Gy to 93.1 ± 5.2 per jejunal circumference. In contrast, 16, 16-dm PGE2 increased ICC survival at 15.0 Gy rapidly from 1 to 10 μg/mouse, followed by a plateau up to 100 μg/mouse. Animal survival at 6 days (${\rm LD}_{50/6}$) increased from 16.3 ± 0.4 Gy (95% confidence limits) in controls to 20.3 ± 0.6 Gy in the PG-treated animals. WR-2721 increased the ${\rm LD}_{50/6}$ to 26.1 ± 1.4 Gy. The dose modification factors were 1.25 and 1.60, respectively. The combination of agents increased ICC survival above that seen with each agent alone up to 8 mg WR-2721, above which no additional protection was seen. Animals given 10 μg PG plus 10 mg WR-2721 survived longer than with either agent given alone. The ${\rm LD}_{50/6}$ was 36.3 ± 1.8 Gy for a dose modification factor (DMF) of 2.23. In addition, the slope of the probit curve was reduced from those of each agent alone. PG-induced changes in villus epithelial cell morphology and survival may account, in part, for these observations. The results suggest that either the mechanisms for these two types of radiation protectors are different or they act on separate subcellular targets which are critical to survival from radiation injury.

Page Thumbnails

  • Thumbnail: Page 
361
    361
  • Thumbnail: Page 
362
    362
  • Thumbnail: Page 
363
    363
  • Thumbnail: Page 
364
    364
  • Thumbnail: Page 
365
    365
  • Thumbnail: Page 
366
    366
  • Thumbnail: Page 
367
    367
  • Thumbnail: Page 
368
    368
  • Thumbnail: Page 
369
    369
  • Thumbnail: Page 
370
    370
  • Thumbnail: Page 
371
    371
  • Thumbnail: Page 
372
    372
  • Thumbnail: Page 
373
    373